Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate as Add-on to Antipsychotics in Schizophrenia
NCT03369795Phase 2Unknown
- Sponsor
- Sheba Medical Center
- Start
- Dec 2017
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of methotrexate in schizophrenia, schizoaffective disorder, sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
methotrexate
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT03369795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03369795.